Atrovastatin-PEG3-FITC

Modify Date: 2024-04-06 14:25:32

Atrovastatin-PEG3-FITC Structure
Atrovastatin-PEG3-FITC structure
Common Name Atrovastatin-PEG3-FITC
CAS Number 1440755-31-6 Molecular Weight 1150.31
Density N/A Boiling Point N/A
Molecular Formula C64H68FN5O12S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Atrovastatin-PEG3-FITC


Atrovastatin-PEG3-FITC (compound S31) is a KRAS-PDEδ interaction inhibitor. Atrovastatin-PEG3-FITC acts as a ligand in fluorescence anisotropy assay[1][2].

 Names

Name Atrovastatin-PEG3-FITC

 Atrovastatin-PEG3-FITC Biological Activity

Description Atrovastatin-PEG3-FITC (compound S31) is a KRAS-PDEδ interaction inhibitor. Atrovastatin-PEG3-FITC acts as a ligand in fluorescence anisotropy assay[1][2].
Related Catalog
Target

KRAS-PDEδ

References

[1]. Gunther Zimmermann, et al. Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signaling. Nature. 2013 May 30;497(7451):638-42.

[2]. Yan Jiang, et al. Structural Biology-Inspired Discovery of Novel KRAS-PDEδ Inhibitors. J Med Chem. 2017 Nov 22;60(22):9400-9406.

 Chemical & Physical Properties

Molecular Formula C64H68FN5O12S
Molecular Weight 1150.31